HIV/AIDS Treatment Trends and Progress: Where Do We Stand Today?
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
KPMG in South Africa goes to market by line of business or industry, serving all of the key sectors across our economy. This focus allows our professionals to understand our clients’ needs rapidly, within the context of their specific business and the broader sector in which they operate. Our people consequently enjoy the growth opportunities that such an environment affords.
KPMG has 12 offices in South Africa, comprising our national office in Johannesburg and regional offices in Bloemfontein, Cape Town, Stellenbosch, Durban, East London, Nelspruit, Pietermaritzburg, Polokwane, Port Elizabeth, Pretoria and Secunda. With over 3,400 staff and more than 230 partners, we are one of the largest Audit, Tax and Advisory firms in the country.
KPMG in South Africa is owned by South Africans, headed up by a democratically elected Board. The Board elects the Chairman and the Chief Executive, who in turn appoints his/her Executive Committee.
We are proud to be South Africans, operating in the global marketplace. Our passion for the country, Transformation (Broad-Based Black Economic Empowerment) and the upliftment of our communities is self-evident.
We also played a pivotal role in bringing a number of our African national practices (including South Africa) together under a separate legal entity – KPMG Africa Limited to allow for seamless operational integration. Our Chief Executive, Trevor Hoole, is the Senior Partner of KPMG in South Africa.
KPMG in South Africa also plays an active role in KPMG’s global network. Roughly 40 professionals from the South African firm have active roles on international KPMG bodies – across the European, Middle Eastern and African (EMA) region and at a global level. With direct representation on KPMG’s International Board and International Council, as well as numerous international committees, working groups and networks, the South African firm is well positioned to think globally and act locally.
Contact
Johannesburg (Head Office)
KPMG Crescent, 85 Empire Road, Parktown, 2193
Private Bag 9, Parkview, 2122
Tel: +27 (0)11 647 7111
Fax: +27 (0)11 647 8000
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
Lenias Hwenda of Medicines for Africa examines the true impact of access to medicine initiatives in Africa, noting that many of the measures takes are often cosmetic and leave a…
Some of the top pharma news coming out of South Africa including Afrigen’s partnership with US National Institutes of Health (NIH), BioNTech’s efforts to bring an mRNA start-to-finish vaccine manufacturing network…
See our Cookie Privacy Policy Here
